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Study objectives: To evaluate the quality of analgesia and the incidence of side effects of 2 different
concentrations of levobupivacaine given as an equal milligram–bolus dose (5 mg) via patient-controlled
epidural analgesia after abdominal surgery.
Design: Prospective, randomized, blinded study.
Setting: Postanesthesia care unit and surgical wards of a university hospital.
Patients: Forty-nine patients (41 with complete file) undergoing major lower abdominal surgery.
Interventions: The patients were randomly assigned to 2 groups: 1.5 mg/mL (bolus 3.3 mL, lockout
20 minutes, n = 26) and 5 mg/mL (bolus 1 mL, lockout 20 minutes, n = 23). The epidural catheter
was inserted in the low thoracic level (T9-T12) before induction of a standardized general anesthe-
sia technique.
Measurements: Demography, upper sensory block, visual analog scale scores at rest and after
coughing, levobupivacaine and rescue morphine consumption, motor blockade, hemodynamics,
postoperative nausea and vomiting, sedation, and patient satisfaction were recorded within the first
48 hours.
Main results: Both groups were similar with regard to demographics, upper level of sensory blockade
(T8), and visual analog scale pain scores at rest and after coughing, as well as levobupivacaine and
subcutaneous rescue morphine consumption. Motor blockade in the lower limbs was very low in both
groups. Arterial blood pressure was slightly lower in the 5 mg/mL group during the first 24 hours (P =
0.052). Five patients in the 1.5 mg/mL and 7 in the 5 mg/mL group had postoperative nausea and
vomiting (P = 0.43). No other side effects were recorded, and all of the patients were satisfied.Journal of Clinical Anesthesia (2005) 17, 531–536Elsevier Inc. All rights reserved.
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M. Dernedde et al.532Conclusions: Administering the same dose of levobupivacaine in either a low or high concentration via
patient-controlled epidural analgesia mode provides an equal quality of analgesia with no difference in
the incidence of side effects.
D 2005 Elsevier Inc. All rights reserved.1. Introduction
The relative effects of mass, volume, and concentration of
local anesthetic solutions used for epidural anesthesia and
analgesia are still subject of debate. In clinical studies [1-5],
contradictory results have been reported, probably due to the
fact that the total dose of local anesthetic was not taken into
consideration. Bromage [6] found that it is the total local
anesthetic dose, and not the total volume, which determines
the spread and quality of analgesia. Others have confirmed
this finding, after both lumbar [7] and midthoracic [8]
epidural administration. Nevertheless, it remains unclear in
the literature whether the concentration influences the quality
of pain relief during epidural analgesia when the total dose is
held constant [9-11]. For continuous thoracic epidural
administration, Dernedde et al [12,13] demonstrated that a
high-concentration/low-volume local anesthetic infusion
provided an equal quality of postoperative analgesia as a
low-concentration/high-volume infusion and induced less
motor blockade as well as less hemodynamic repercussions.
In patient-controlled epidural analgesia (PCEA), to date,
only 2 studies have evaluated the influence of volume and
concentration of the local anesthetic [14,15]. Both studies
highlighted that the quality of analgesia was comparable
with either low or high concentrations of the local anesthetic,
but with reduced motor blockade [14] and drug consumption
[15] using a low-concentration/high-volume approach.
Based on our previous results with continuous thoracic
epidural administration of local anesthetics, we designed a
prospective, randomized, double-blind study to compare
2 different concentrations of levobupivacaine, 1.5 and
5 mg/mL, given in equal total milligram–bolus doses
(ie, 5 mg), via PCEA mode after lower abdominal surgery.2. Materials and methods
After approval by the University Hospital Center Ethics
Committee, written informed consent was obtained from 49
consecutive American Society of Anesthesiologists physical
status I, II, and III patients undergoing elective lower
abdominal surgery. Patients were enrolled in the study if
they were between 18 and 75 years old, were able to read
and understand French, had normal mental health, and were
being hospitalized for elective surgery. Exclusion criteria
were sepsis, allergy to amide-type local anesthetics or
morphine, and coagulopathy. At the time of the preoperative
visit, patients were familiarized with a 10-cm visual analog
scale (VAS) device for pain (0 = no pain at all, 10 = worstimaginable pain) and nausea [16] intensity assessment
(0 = no nausea at all, 10 = worst imaginable nausea).
Patients were premedicated with either midazolam 3 to
6 mg administered intramuscularly 1 hour before induction
of anesthesia or with alprazolam 0.5 to 0.75 mg orally in the
morning of the intervention. In the operating room, after
infusion of 500 mL Ringer solution via an intravenous (IV)
cannula, a 20-gauge epidural catheter was inserted through
an 18-gauge Tuohy needle into the epidural space at a low
thoracic level. The epidural catheter was directed cephalad
for a distance of 4 cm and fixed to the back of the patient.
As soon as the patient was in the supine position, a test dose
of 3 mL 5 mg/mL levobupivacaine (Chirocaine, Abbott,
Belgium) was injected to exclude subarachnoid positioning
of the catheter as proposed by Murdoch et al [17] and
Daoud et al [18].
Standardized general anesthesia was maintained with
sevoflurane in 50% oxygen in air or nitrous oxide associated
with sufentanil and myorelaxant. Based on an antiemetic
institutional policy [19], 2 mg tropisetron (Novaban,
Novartis, Belgium) was administered to all patients. Three
to 6 mL of 5 mg/mL levobupivacaine was injected through
the epidural catheter for the surgical procedure. If surgery
lasted longer than 2 hours, patients received an additional
injection of half of the original volume of the local anesthetic
using the same concentration. After completion of the
operation and tracheal extubation, patients were transferred
to the postanesthesia care unit where they remained under
constant observation for approximately 4 hours. The patients
received, in a random fashion using a computer-generated
randomization schedule, either 1.5 mg/mL levobupivacaine
as a 3.3-mL bolus on demand, with a lockout interval of
20 minutes (n = 26), or 5 mg/mL levobupivacaine as a 1-mL
bolus on demand, with a similar lockout interval (n = 23) via
a PCEA pump (Abbott aim plus, Abbott Laboratories, North
Chicago, Ill). No additional bolus injections were allowed.
Patients received multimodal analgesia consisting of every
6-hour IV propacetamol (2 g) and ketorolac (60 mg daily)
for postoperative pain relief. Rescue medication with
morphine was provided via subcutaneous injections after
each 4-hour evaluation of the VAS scale. Subcutaneous
morphine consumption during the 48-hour study period
was recorded by the nurses who administered the drug. After
48 hours, PCEAwas discontinued, and alternative analgesia
was provided.
On arrival in the postanesthesia care unit, patients were
asked to rate their pain experience on the VAS device. This
process was repeated every 2 hours for the first 4 hours and
continued every 4 hours for 48 hours after the patient was






Sex (male/female) 7/14 9/11 0.44
Age (y) 54 F 11 54 F 13 0.86
Weight (kg) 73 F 14 75 F 16 0.67
Height (cm) 167 F 10 168 F 9 0.72
BMI (kg/m2) 26 F 4 27 F 5 0.64
ASA class 0.40
I 4 (19%) 2 (10%)
II 13 (62%) 16 (80%)
III 4 (19%) 2 (10%)
Type of surgery 0.54
Urological (n) 2 4
Gynecologic (n) 12 10
Visceral (n) 7 6
Concentration (mg/mL) refers to levobupivacaine. BMI indicates body
mass index; ASA, American Society of Anesthesiologists.
Fig. 1 Evolution of the mean upper sensory dermatomal level in
the 2 groups of patients during the 48-hour study period.
Concentration (1.5 and 5 mg/mL) refers to levobupivacaine. Error
bars indicate SD. Th indicates thoracic. No significant difference
between the 2 groups of patients (P = 0.68, GLMM statistic).
*P b 0.05 (Student t test).
Comparison of 2 concentrations of levobupivacaine 533moved to the general surgical ward. Pain at rest, defined as
the pain experienced by the patient while lying in bed, and
pain while coughing were assessed. The pain threshold was
set at 3 cm on the VAS scale [20]. Nausea intensity was
evaluated using a VAS device, and vomiting was recorded
as either present or absent by direct observation or by
spontaneous complaint of the patient. Nausea was defined
as a patient’s rating score superior to 4 cm on the VAS [16].
Rescue medications given for nausea and/or vomiting were
recorded. Motor blockade in the lower limbs was assessed
according to a modified Bromage scale [21] (0 = no motor
block, 1 = inability to flex hips, 2 = inability to flex knees,
and 3 = inability to flex ankle joints). The cephalad level of
sensory block was evaluated by loss of sensation to cold
using ether swabs. If the levels of sensory block on the right
and left sides were different, the most-cephalad level was
recorded. The anesthetist and the nurse investigators were
blinded to the type of epidural solution administered.
Hypotension was defined as a 20% decrease of systolic
blood pressure (SBP) compared with baseline and an SBP
less than 90 mm Hg [22]. Bradycardia was defined as a heart
rate less than 50 beats per minute, and bradypnea as a
respiratory rate less than 10 breaths per minute. Sedation was
recorded on a 4-point scale (0 = no signs of sedation, 1 = mild
sedation, 2 = moderate sedation, and 3 = severe sedation).
During the first 48 hours, the patients were visited by a
pain nurse from the Acute Pain Service, who interviewed
each patient regarding satisfaction with postoperative
analgesia. The quality of pain management was judged
by the patient on a 4-point scale (1 = very dissatisfied,
2 = dissatisfied, 3 = satisfied, and 4 = very satisfied).
2.1. Statistical analysis
Results were expressed as means F SD for quantitative
variables and as frequencies for categorical findings.
Time-related VAS measurements were summarized usingdifferent pain indicators as described elsewhere [12,13,20]:
AUC, area under the VAS-time curve (cm2); mean VAS
(cm); VASmax, peak of VAS (cm); Tmax, time of VASmax
(hour); PVAS N3, the persistence of VAS more than 3 cm
(ie, the period during which VAS was more than the critical
threshold [hour]); and Pdur, pain duration (ie, the period
during which the patient reported pain [VAS N0]) over the
48 hours (hours). The comparison of mean values was done
by Wilcoxon test, whereas proportions were compared
by the classical v2 test. The general linear mixed model
(GLMM) was used to analyze repeated measures of
continuous data. The GLMM tests 2 null hypotheses as
follows: (1) time has no effect on the variable, which means
that the variable mean of the combined groups does not vary
over time, and (2) the time patterns are equal between the
2 groups, which means that the difference between the mean
of each group is the same at every time point. The
Bonferroni test, based on Student t statistic, was used for
post hoc testing. The number of patients included in the
study was based on our previous results and on a power
calculation assuming a 20% difference with a = .05 and
b = .20 [12,13]. All statistical calculations were carried
out by means of the SAS package (SAS Institute, Cary,
NC, version 6.12) and always using all available data.
Results were considered to be significant at the 5% critical
level (P b 0.05).3. Results
In our study, 8 patients were excluded because of
protocol deviations, lack of data recording, or accidental
removal of the catheter. A total of 41 patients with
completed case report forms were included in the study
(21 in the 1.5 mg/mL group and 20 in the 5 mg/mL group).
For these patients, epidural catheters were functioning until
the end of the observation period. Table 1 displays patients’
Fig. 2 Evolution of the mean VAS scores at rest and at
coughing, expressed in centimeter in the 2 groups of patients
during the 48-hour study period. Concentration (1.5 and 5 mg/mL)
refers to levobupivacaine. Error bars indicate SD. No significant
difference was found between the 2 groups of patients at rest
(P = 0.81) and at coughing (P = 0.96) using the GLMM statistic.
*P b 0.05 (Student t test).








AUC (cm2) 56.0 F 52.6 54.0 F 28.7 0.59
VASmax (cm) 4.3 F 2.4 3.9 F 1.9 0.59
VAS mean (cm) 1.2 F 1.1 1.3 F 0.8 0.81
PVAS N3 (h) 5.9 F 10.4 4.3 F 4.8 0.51
At coughing
AUC (cm2) 89.7 F 59.2 90.6 F 49.7 0.96
VASmax (cm) 5.6 F 2.5 5.1 F 1.9 0.43
VAS mean (cm) 2.1 F 1.3 2.1 F 1.1 0.96
PVAS N3 (h) 10.4 F 11.7 12.1 F 11.0 0.64
Concentration (mg/mL) refers to levobupivacaine.






Levobupivacaine 24 h (mg) 100 F 47 106 F 46 0.35
Levobupivacaine 48 h (mg) 65 F 67 72 F 68 0.14
Morphine 24 h (mg) 7.9 F 10.5 6.7 F 7.0 0.98
Morphine 48 h (mg) 1.5 F 5.4 0.4 F 1.6 0.63
Propacetamol 24 h (g) 8 F 0 8 F 0 N0.99
Propacetamol 48 h (g) 8 F 0 8 F 0 N0.99
NSAIDs (n) 17 (81%) 15 (75%) 0.72
Antiemetic drugs (n) 5 (24%) 7 (35%) 0.43
Concentration (mg/mL) refers to levobupivacaine. NSAIDs indicates
nonsteroidal anti-inflammatory drugs.
M. Dernedde et al.534characteristics and distribution according to the type of
surgery. The demographic data baseline recordings and the
type of surgery were similar in the 2 groups. Specifically,
there was no difference in the age range between groups.
The level of insertion of the epidural catheter was low
thoracic (T9-T12), with no differences between the 2 groups
(P = 0.29). No cases of accidental dural puncture occurred.
At the time of surgery, patients received the same amount
of IV sufentanil (23 F 9 lg in the 1.5 mg/mL group and
23 F 7 lg in the 5 mg/mL group, P = 0.96). There was no
difference between the groups in the amount of epidural
levobupivacaine used for surgery (51 F 16 mg in the
1.5 mg/mL group and 53 F 14 mg in the 5 mg/mL,
P = 0.70). Fig. 1 illustrates the mean upper level of sensory
blockade at the different time points after surgery. There was
no difference between the 2 groups (P = 0.68, GLMM
statistics), except at 40 hours, whereupon there was a
significantly higher mean upper level in the 1.5 mg/mL
group (P = 0.041).Fig. 2 shows VAS pain scores at rest and after coughing
during the first 48 postoperative hours in the 2 groups.
GLMM statistics of the VAS scores for pain showed no
difference between the 2 groups, except that the VAS pain
score was significantly superior in the 5 mg/mL group (P =
0.045) only at the 4-hour time point. Table 2 displays the
values of the pain indicators. We noted that the scores for
AUC, VASmax, VAS mean, and PVAS N3 were similar in the
2 groups. Furthermore, we highlight a strong positive
relationship between the VAS scores at rest and at coughing
(r = 0.62, P b 0.0001). The type of surgery did not influence
the efficacy of pain relief.
Table 3 displays postoperative analgesic consumption.
Mean consumption of epidural levobupivacaine during the
first 24 hours amounted to 100 F 47 mg in the 1.5 mg/mL
group and 106 F 46 mg in the 5 mg/mL group (P = 0.35).
Propacetamol was given to all patients, and ketorolac was
administered to 17 patients (81%) in the 1.5 mg/mL group
and to 15 (75%) in the 5 mg/mL group (P = 0.72). Rescue
analgesia, represented by morphine consumption (subcuta-
neous), was similar in the 2 groups. In the first 24 hours,
the mean consumption of morphine was 7.9 F 10.5 mg in
the 1.5 mg/mL group, compared with 6.7 F 7.0 mg for the
5 mg/mL group (P = 0.98). During the second postoperative
day, morphine use was reduced to 1.5 F 5.4 mg in the
Fig. 3 Evolution of mean SBP and diastolic BP in the 2 groups of patients during the 48-hour study period. Concentration (1.5 and 5 mg/mL)
refers to levobupivacaine. Error bars indicate SD. Systolic and diastolic BPs expressed in millimeters of mercury were lightly lower in the
5 mg/mL group during the first 24 hours (P = 0.05, GLMM statistic). *P b 0.05 (Student t test). Sys indicates systolic; dia, diastolic.
Comparison of 2 concentrations of levobupivacaine 5351.5 mg/mL group versus 0.4 F 1.6 mg in the 5 mg/mL
group (P = 0.63). No life-threatening respiratory events
associated with opioid administration were reported during
the study period.
Finally, motor blockade was consistently low in all
patients (mean Bromage score b1) without any difference
between the 2 groups. Fig. 3 displays the evolution of the
SBP and diastolic blood pressure. We note that arterial blood
pressure (BP) was slightly lower in the 5 mg/mL group
during the first 24 hours (P = 0.052, GLMM statistics),
which occurred after 1, 36, and 40 hours. During the study
period, no vasoconstrictors or atropine was given for
treatment of hypotension or bradycardia. We point out that
5 patients (24%) in the 1.5 mg/mL group had nausea
compared with 7 (35%) in the 5 mg/mL group (P = 0.43).
We observed no sedation, respiratory depression, or pruritus
in any patient. All patients in the 2 groups were either
satisfied or very satisfied regarding the quality of their pain
management.4. Discussion
The results of the present study confirm that altering the
concentration and the volume while maintaining equivalent
total-milligram doses of levobupivacaine administered via
thoracic PCEA resulted in the same quality of analgesia,
both at rest and after coughing. Local anesthetic require-
ments were similar in both groups during the 48-hour study
period. We chose to administer a 5-mg-bolus dose with a
lockout interval of 20 minutes. This dose corresponds to a
maximum of 15 mg/h of the local anesthetic similar to what
we have used in previous studies of continuous epidural
infusion [12,13]. These results are consistent with previous
studies supporting the view that the quality of epidural
analgesia depends on the total mass of local anesthetic and
not on the volume or concentration [2,6,12-15,23].
We used plain levobupivacaine 5 mg/mL for epidural
infusion at a low thoracic level. The concentration was
selected to maximize the analgesic effects of the local anes-thetic in the thoracoabdominal somatosensory distribution
[24]. As proposed by Duggan et al [2], a low volume of
a concentrated solution produces the most predictable
extradural block. The cephalad extent of the sensory block
(T8) was similar in both groups. We recorded only the mean
upper sensory block, and therefore, we cannot make any
statement about the segmental block (ie, the number of
segments blocked).
We placed our epidural catheters in low thoracic vertebral
interspaces, which is typical practice for patients undergoing
lower abdominal surgery. However, the placement of
epidural catheters in such proximity to the lumbar spinal
segments, which provide motor innervation to the lower
extremities, could increase the risk of motor block when
compared with a midthoracic approach, especially in the
high-volume group [25]. Nevertheless, lower limb motor
block was consistently low in all patients, and we did not
observe any difference between the 2 groups.
Although there was no statistically significant difference
in hemodynamic parameters, patients in the 5 mg/mL group
had a slightly lower BP without any hypotensive episodes.
As previously mentioned, Liu et al [14], when using PCEA
after lower abdominal surgery, observed that a lower
concentration of a similar amount of epidural ropivacaine/
fentanyl provides equal analgesia with less motor blockade
when compared with higher concentrations of the local
anesthetic. Epidural catheters were placed at the T12 to L2
interspace. Placement of catheters in proximity to lumbar
spinal segments increases the risk of motor block when
compared with a more cephalad approach [26]. Whiteside
et al [15] using the same association of drugs after gynecol-
ogic surgery showed that a low-concentration/high-volume
PCEA appears satisfactory to treat postoperative pain and
reduce the dose of the drugs used in comparison with a low
volume/high concentration. Our study differs considerably
because we did not add any epidural opioids to focus solely
on the local anesthetic action. Addition of a high volume
of fentanyl to the local anesthetic could produce a more
extensive sensory block as a result of greater anatomic
spread and interaction with opioid receptors [9,27]. Opioids
M. Dernedde et al.536also limit the regression of postoperative analgesia observed
with local anesthetics alone and improve the quality of pain
relief [28,29]. This fact makes a comparison with our
results difficult.
The most important limitation related to our study design
is that our patients received multimodal analgesia, which
might have masked slight differences in the intensity of rest
pain between the 2 groups. Nevertheless, as stated by Kehlet
and Holte [30], the best quality of postoperative analgesia is
achieved by systemic analgesics combined with an epidural
approach. We routinely use this analgesic regimen, and we
conducted our study in a clinical setting. Further studies
should also examine the quality of analgesia with other
infusion rate modalities (ie, supplemental night-time infu-
sion in PCEA, as proposed by Komatsu et al [31]).
It should be noted that the plain 5 mg/mL levobupiva-
caine solution is ready to use. Thus, the risk of administra-
tion errors decreases, as well as the nursing time and
pharmacy preparation costs.
In conclusion, the 2 concentrations of levobupivacaine
(5 and 1.5 mg/mL) given as a 5-mg-bolus dose PCEA
induce similar quality of postoperative analgesia without
any difference in the frequency of side effects.References
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